Chatterjee et al. [3] have proved that combined IDH1 and ATRX IHC can accurately confirm the molecular nature of most grade 1 astrocytomas and grade 3 astrocytoma cases, thereby avoiding the need for expensive investigations such as gene sequencing. This evidence concerns the gene IDH1 and astrocytoma (excluding glioblastoma).